Shield Therapeutics PLC banner

Intrinsic Value

The intrinsic value of Shield Therapeutics PLC (1JS) under the Base Case is 0.073 EUR per share. Compared with the current market price of 0.037 EUR, the stock appears Undervalued by 49% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

1JS Intrinsic Value
€0.073
Undervaluation 49%
Intrinsic Value
Price €0.037
Alert me when 1JS is below its intrinsic value
Today €0.036 · 1.4% below the current price

1JS is cheaper than usual. It was this cheap or cheaper on just 7% of days in the past 5 years.

Alternatives to 1JS

Fundamental Analysis

What Shield Therapeutics Does

Pharmaceuticals Health Care

Shield Therapeutics is a specialty pharmaceutical company focused on treating iron deficiency and iron deficiency anaemia. Its main product is an oral iron medicine designed for patients who cannot tolerate standard iron pills or who need a different way to replace iron. The company sells prescription medicine to healthcare providers and pharmacies, so the real customers are doctors, hospitals, and patients using the treatment under medical supervision.

Headquarters
United Kingdom UK
Employees
63
IPO date
Feb 26, 2016
Read the full company overview
View Company Overview
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Continue 1JS Research

Decided on Shield Therapeutics? Get an email when 1JS reaches the price you’d buy at. Free with an account.

Other Shield Therapeutics listings

What is the Intrinsic Value of one 1JS stock?

The intrinsic value for Shield Therapeutics PLC (1JS) under the Base Case is 0.073 EUR.

Is 1JS stock undervalued or overvalued?

Compared with the current market price of 0.037 EUR, the stock appears Undervalued by 49% .

How reliable are our estimates? See how past valuations played out
Back to Top